First Epinephrine autoinjector approved for infants

EpiPen (CBS This Morning)
Published:
Updated:

Encouraging news for parents with babies or small children who have life-threatening allergies.

The US Food and Drug Administration has just approved the first and only epinephrine autoinjector specifically for treating infants and children weight 16.5 to 33 pounds.

The development is being reported online by Medscape, an online website reporting the latest medical news for physicians and healthcare professionals.

The FDA approval comes at a critical time with recent food guidelines suggesting that certain high-risk infants ---as young as four to six months old—can be introduced to foods that contain peanuts.

The pharmaceutical company, Kalèo, was approved for the new drug for the Auvi-Q epinephrine injector.

The inject is small and includes a voice prompt system that gives step-by-step instructions.

The new injector has a shorter needle length and a lower dose of epinephrine.

The company said the shorter needle will help avoid striking a bone which could not only cause an injury but also interfere with the delivery of the life-saving epinephrine.